Mammography Market Size, Share, Growth Analysis, By Product(film screen systems, digital systems, analogue systems and 3-D systems), By end use(hospitals, speciality clinics, diagnostic centres and others), By technology(breast tomosynthesis, CAD mammography, and digital mammography), By Region - Industry Forecast 2024-2031

Mammography Market size was valued at USD 2 million in 2019 and is poised to grow from USD 2.2 million in 2023 to USD 4.63 million by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

The mammography market is characterized by intense competition between global and regional players, each vying to grow its product offerings and strengthen its market presence. Competition with technology into continuous growth, strategic business, mergers and acquisitions, and focus on expanding penetration into the underserved regions. The market is organized and segmented into manufacturers of digital mammography systems, 3D mammography (tomosynthesis) devices, and artificial intelligence-assisted mammography solutions. The company has a strong presence in North America and Europe and has continued to invest in research and development (R&D) to remain at the forefront of innovation. 'Hologic Inc.', 'Fujifilm Corporation', ' GE Healthcare ', ' Siemens Healthineers ', ' Koninklijke Philips N.V. ', ' Metaltronica S.p.A. ', ' Planmed Oy ', ' Carestream Health, Inc. ', ' BMI Biomedical International S.r.l. ', ' Allengers Medical Systems Ltd. ', ' General Medical Italia S.p.A. ', ' Amico JSC ', ' Delphinus Medical Technologies, Inc. ', ' Aurora Imaging Technology, Inc. ', ' CMR Naviscan Corporation ', ' Micrima Limited ', ' iCAD Inc. ', ' KUB Technologies Inc. ', ' Solis Mammography ', ' Siemens AG '

One of the major drivers of the mammography market is the increasing incidence of breast cancer across the globe. As breast cancer is one of the most common cancers among women, early detection and prevention are of utmost importance and as a result, screening programs are being enacted by healthcare organizations and governments encourage breast screening, especially in developed countries. This improved awareness of early detection has brought about a massive demand for superior breast screening structures, using the marketplace ahead. 

Switch to Artificial Intelligence (AI)-Assisted Mammography: AI tools are increasingly being followed in breast screening to help radiologists identify diffused abnormalities that can be overlooked all through the manual evaluation. A key fashion inside the mammography marketplace is the integration of artificial intelligence (AI) into breast screening structures. AI-assisted mammography can fast and accurately examine mammogram pix, improving the early detection and lowering the human errors. 

The mammography market in North America accounted for the largest global revenue share of 35.80% in 2023. The rising incidence of breast cancer in this region is one of the major factors driving the market growth but 56,500 breast cancers have been diagnosed there in women, and the number of breast cancer cases is predicted to rise in the coming years. Owing to the high prevalence of breast cancer and major market players in the country, North America accounted for the largest share in the market growth in the regional market in 2023. These factors are expected to drive the demand for breast screening devices and thus support the market growth.